News

EXACT’s total revenues increased due to strategic relationship with Genzyme Corp. Exact in January entered into an intellectual property transaction with Genzyme that generated $17.2 million in cash.

Excelsior Medical, a medical device company, has received 510k clearance to sell its SwabCap luer access valve disinfection cap. According to Excelsior Medical, SwabCap is designed to assist

Juan Han, chairman and CEO of China Aoxing, said: “We are very excited to have another drug approval in year 2009. This approval further underscores China Aoxing’s long-term

Under the shared risk-reward collaboration, which will initially focus on the neuroscience area, Jubilant aims to deliver a steady stream of discovery programs to AstraZeneca. AstraZeneca will own

Izasa will target early adopters who recognize the benefits of utilizing the unique fluid balancing capabilities of RenalGuard in a cath lab setting during cardiovascular imaging procedures for

The strategic partnership will allow Lima Corporate to distribute select DJO Surgical products in several countries in Europe, while Lima Corporate will provide products for sale in the

AstraZeneca has also submitted a supplemental new drug application (sNDA) for Nexium for the risk reduction of low dose aspirin-associated gastric and/or duodenal ulcers. Nexium already is approved

ZymoGenetics has received rights to potential milestones and royalties, in exchange for licensing Seattle Life Sciences (SLS) rights to develop the product candidates. In addition, ZymoGenetics is entitled

The company has recently completed a Phase III clinical trial in the US with its flagship IV Alpha-1 Antitrypsin (AAT) product indicated for treating AAT deficiency and is